Fig. 3From: Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461Telomerase-associated parameters compared with overall survival. Kaplan–Meier estimates revealed a significant survival benefit for glioma patients lacking hTERT+β (Right) or TA (Left) in different WHO grade gliomas including 38 GBMs (a), 23 ODMs (b) and 35 OAMs (c)Back to article page